Nevertheless, given the fact that only 4% of ccRCCs present with p53 mutations, enhanced G6PD activities to direct glucose toward biosynthesis and increased tumor cells growth may not be due to p53 inactivation in RCC [46]. The gene discussed is G6PD; the disease is neoplasm.